Related Experiment Video
Updated: Apr 24, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Advances in autosomal dominant polycystic kidney disease-2014 and beyond
1Department of Nephrology and Hypertension, Glickman Urological and Kidney Institute, Cleveland Clinic, one of seven US centers participating in the HALT-PKD collaborative study braunw@ccf.org.
Insights
Autosomal dominant polycystic kidney disease (ADPKD) lacks specific treatments, often progressing to end-stage renal disease. Recent research improves diagnosis and identifies promising new therapeutic strategies for ADPKD.
Area of Science:
- Nephrology
- Genetics
- Pharmacology
Background:
- Autosomal dominant polycystic kidney disease (ADPKD) is a common genetic disorder.
- ADPKD frequently results in end-stage renal disease (ESRD).
- Current therapeutic options for ADPKD are limited, lacking specific disease-modifying drugs.
Purpose of the Study:
- To review recent advancements in understanding ADPKD pathogenesis.
- To discuss progress in diagnostic accuracy for ADPKD.
- To highlight emerging therapeutic strategies and clinical trial outcomes for ADPKD.
Main Methods:
- Literature review of recent studies on ADPKD.
- Analysis of clinical trial data for ADPKD treatments.
- Synthesis of information on ADPKD diagnosis and management.
Main Results:
- Improved understanding of ADPKD molecular mechanisms.
- Enhanced diagnostic tools for identifying ADPKD and its complications.
- Identification of several promising drug candidates and therapeutic approaches in clinical trials.
Conclusions:
- Despite challenges, significant progress has been made in ADPKD research.
- New diagnostic and therapeutic avenues offer hope for ADPKD patients.
- Further research and clinical trials are crucial for developing effective ADPKD treatments.
Abstract:
Autosomal dominant polycystic kidney disease (ADPKD), which frequently leads to end-stage renal disease, currently has no specific drug therapies. Better understanding of its pathogenesis and recent clinical trials have led to more accurate diagnosis of the disease and its manifestations, as well as to promising new approaches to treatment.
More Related Videos
08:46Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
12:47Spectral Karyotyping to Study Chromosome Abnormalities in Humans and Mice with Polycystic Kidney Disease
Published on: February 3, 2012
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Diabetic Nephropathy
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Nephrons
Chronic Kidney Disease II: Clinical Manifestations